SRPT

#1698
Sarepta Therapeutics, Inc. - Common Stock
17.8 7 USD
+3.24%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
17.87
17.87
Faixa anual
10.41
43.91
Mudança diária
+3.24%
Mudança mensal
-14.78%
Mudança em 6 meses
-14.74%
Mudança anual
-53.04%
Fechamento anterior
17.3 1
Open
17.8 7
Mínimo
17.8 7
High
17.8 7
Volume
188
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.89 B
  • Employee 835
  • Founded 1980
  • CEO Douglas S. Ingram
  • Website www.sarepta.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCJ161
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-3.02
Índice preço/fluxo de caixa
0.98

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

Notícias